Nivolumab is under clinical development by Bristol-Myers Squibb and currently in Phase II for Extrahepatic Bile Duct Cancer. According to GlobalData, Phase II drugs for Extrahepatic Bile Duct Cancer ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

1 Most cystadenomas arise within the intrahepatic bile ducts.2 3 Very rarely these lesions are found in the extrahepatic biliary system and gallbladder.4 Women are more commonly affected with a mean ...

Tissue samples of 71 patients with ECC (i.e., pCCA) who underwent resection were stained to assess hENT1 expression. Of these, 41 patients underwent a major hepatectomy which included a resection of ...

Although much research on the mechanisms of portal hypertension has focused on liver fibrosis, less attention has been given to the role of intrahepatic and extrahepatic vascular dysfunction, ...

Correspondence to Dr Guangchuan Wang, Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China; riverwang{at}126.com; Dr Shan Shan, Liver ...

FOR the 6,000 people in the UK who are newly diagnosed with bile duct cancer every year, the prognosis is uniquely grim. According to data from Cancer Research UK, up to 70 per cent of all these ...

All cases were required to have had at least one colonoscopy with biopsies at the Mayo Clinic. Conventional radiographic criteria of beading, duct ectasia, and stricturing of the intra- or ...

Doctors in the UK are hoping to transform the lives of people with deadly bile duct cancer. A new study – which has shown promising early results – matches the patient’s tumour to one or ...